Privi Speciality Chemicals Invests ₹25.50 Crore in Joint Venture with Givaudan SA
Privi Speciality Chemicals Limited completed a ₹25.50 crore investment in its joint venture Prigiv Specialties Private Limited on March 26, 2026, alongside partner Givaudan SA's ₹24.50 crore contribution. The combined ₹50 crore capital infusion increased the joint venture's total paid-up capital from ₹35 crore to ₹85 crore. Privi maintains majority ownership at 51% while Givaudan holds 49%, strengthening their strategic partnership established under the July 29, 2021 Joint Venture Agreement.
*this image is generated using AI for illustrative purposes only.
Privi Speciality Chemicals Limited has successfully completed a major capital expansion in its joint venture with Swiss fragrance giant Givaudan SA. The company announced on March 26, 2026, that both joint venture partners have subscribed to additional equity shares in Prigiv Specialties Private Limited, significantly strengthening the venture's financial foundation.
Capital Infusion Details
The Board of Directors of Prigiv Specialties Private Limited approved the circular resolution for equity share allotment on March 26, 2026. The preferential allotment was executed at ₹10 per equity share, with both partners making substantial investments to expand the joint venture's capital base.
| Shareholder | Investment Amount | Number of Shares Allotted |
|---|---|---|
| Privi Speciality Chemicals Limited | ₹25.50 crore | 2.55 crore |
| Givaudan SA, Switzerland | ₹24.50 crore | 2.45 crore |
| Total Investment | ₹50.00 crore | 5.00 crore |
Shareholding Structure Post-Allotment
Following the capital infusion, the ownership structure of Prigiv Specialties reflects the strategic partnership between the two companies. The expanded capital base demonstrates both partners' commitment to growing their collaborative venture.
| Shareholder | Pre-Allotment Capital | Post-Allotment Capital | Shareholding Percentage |
|---|---|---|---|
| Privi Speciality Chemicals Limited | ₹17.85 crore | ₹43.35 crore | 51% |
| Givaudan SA, Switzerland | ₹17.15 crore | ₹41.65 crore | 49% |
| Total Paid-up Capital | ₹35.00 crore | ₹85.00 crore | 100% |
Joint Venture Background
The capital subscription aligns with the Joint Venture Agreement originally entered into between Privi Speciality Chemicals Limited and Givaudan SA on July 29, 2021, along with subsequent Amendment Agreements. This structured approach ensures both parties maintain their strategic positions while providing necessary capital for business expansion.
Strategic Implications
The substantial capital increase from ₹35 crore to ₹85 crore represents a 142.86% growth in the joint venture's financial capacity. Privi Speciality Chemicals maintains its majority position with 51% ownership, while Givaudan SA holds a significant minority stake at 49%. This balanced partnership structure allows both companies to leverage their respective expertise in the specialty chemicals sector while maintaining strategic control proportionate to their investments.
Historical Stock Returns for Privi Speciality Chemicals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.29% | +0.94% | -2.79% | +25.07% | +81.53% | +244.53% |
What specific expansion projects or new product lines will Prigiv Specialties pursue with the ₹50 crore capital infusion?
How might this strengthened partnership position Privi Speciality Chemicals against competitors in the global fragrance and specialty chemicals market?
Will the expanded financial capacity enable Prigiv Specialties to enter new geographic markets or establish additional manufacturing facilities?
20
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
